News & Events Year None20202019201820172016201520142013201220112009 04/22/20 REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD 03/31/20 REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder 03/09/20 REGENXBIO to Present at the Barclays Global Healthcare Conference 02/26/20 REGENXBIO Reports Fourth Quarter and Full-Year 2019 Financial Results and Operational Highlights 02/19/20 REGENXBIO To Host Conference Call on February 26 to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Operational Highlights 01/29/20 REGENXBIO Announces Presentations at the 16th Annual WORLDSymposium™ 2020 01/09/20 REGENXBIO Reports Continued Progress Across Programs in Year-End 2019 Corporate Update Pagination First page « first Previous page ‹ previous Page 1 Current page 2
